| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8793840 | Ophthalmology | 2018 | 8 Pages |
Abstract
The IBI-10090 dexamethasone drug-delivery suspension placed in the anterior chamber after cataract surgery at concentrations of 342 and 517 μg was safe and effective in treating inflammation occurring after cataract surgery and may be an alternative to corticosteroid drop installation in this patient population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Eric MD, Edward MD,